Award Management

For post award administration, the Office of Sponsored Programs (OSP) and Treasury Billing Services (TBS), performs the financial management on sponsored projects for Duke University. The Office of Research Administration (ORA) coordinates with OSP & TBS to ensure award documentation is processed to initiate the financial services provided by OSP & TBS.

These financial services include the (WBSE set up,) preparation of financial reports, monitoring financial transactions for compliance with sponsor and Duke policies, confirming reimbursement of project encumbrances, and providing training and support to department administrators.

When providing correspondence in a written format to ORA and OSP or TBS, please provide ORA the Sponsored Projects System (SPS) record number and for OSP or TBS identify the WBS Element / fund code for inquiries on sponsored projects.

OSP may be reached at (919) 684-5442 to assist with any questions about the post award process or to schedule individual appointments between department administrators and OSP staff.

Indirect Costs

Indirect Costs are also known as Facilities & Administrative (F&A) Costs or Overhead Costs which are incurred for common or joint objectives and, therefore, cannot be identified readily and specifically with a particular sponsored project, an instructional activity, or another institutional activity.

All applications for sponsored research, education, and outreach (public service) projects will generally have associated F&A costs. These F&A charges are real expenses incurred in the conduct of projects and need to be recovered from the sponsor. It is expected that the standard F&A rate will be used in all applications. If the rate indicated is a nonstandard rate, please refer to Duke University School of Medicine's guidelines that can be found at the following link:

School of Medicine's F&A Rate and Guidelines


F&A Rates for Clinical Research

On-campus clinical research 59%
Off-campus clinical research 28.5%
Industry-funded clinical trial* 28%

*Duke uses the NIH definition of clinical trial